Skip Navigation LinksHome > November 1990 - Volume 73 - Issue 5 > Oral Midazolam Preanesthetic Medication in Pediatric Outpati...

Oral Midazolam Preanesthetic Medication in Pediatric Outpatients.

Feld, Lawrence H. M.D.; Negus, Jean B. M.D., FFARS; White, Paul F. Ph.D., M.D.

Collapse Box


A need exists for a safe and effective oral preanesthetic medication for use in children undergoing elective surgical procedures. We evaluated the effectiveness of three different doses of oral midazolam when administered in combination with atropine prior to ambulatory surgery. In this randomized, double-blind, placebo-controlled study, 124 children, ages 1-10 yr, received midazolam, 0.25, 0.50, or 0.75 mg[middle dot]kg-1 po, and atropine, 0.03 mg[middle dot]kg-1 po, mixed with apple juice, or a placebo (containing the midazolam vehicle, atropine, and apple juice). A blinded observer noted the child's level of sedation, the quality of separation from parents, and the degree of cooperation with an inhalation induction of anesthesia. Picture-recall was used to assess the amnesic effect of midazolam in children over 5 yr of age. Midazolam 0.75 mg[middle dot]kg-1 produced significant sedation at 30 min. After procedures lasting an average of 106-113 min, recovery was not prolonged by the oral midazolam-atropine combination. We concluded that oral midazolam 0.5-0.75 mg[middle dot]kg-1 is an effective preanesthetic medication for pediatric outpatients.
(C) 1990 American Society of Anesthesiologists, Inc.
Publication of an advertisement in Anesthesiology Online does not constitute endorsement by the American Society of Anesthesiologists, Inc. or Lippincott Williams & Wilkins, Inc. of the product or service being advertised.

Article Tools


Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.